Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Non-invasive prenatal diagnosis of thalassemias using maternal plasma cell free DNA.

Best practice & research. Clinical obstetrics & gynaecology - 1 Feb 2017

Hudecova Irena, Chiu Rossa W K

Abstract excerpt

Non-invasive prenatal testing (NIPT) using maternal plasma cell free DNA has already reshaped the existing prenatal care system for pregnancies screened for common chromosomal aneuploidies. On the other hand, much progress has been made in developing NIPT for monogenic diseases. Thalassemia served as a disease model to develop strategies for NIPT of monogenic traits. One approach focuses on the detection or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha-Thalassemia
Share to beta-Thalassemia
Share to DNA

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Hemoglobins

Share to Mutation

Share to Pregnancy

Share to Prenatal Diagnosis

Source

Identifiers

PMID: 27887921
DOI: 10.1016/j.bpobgyn.2016.10.016

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Non-invasive prenatal diagnosis of thalassemias using maternal plasma cell free DNA.PMID 27887921Read ↗

Research Progress of Cell-Free Fetal DNA in Non-Invasive Prenatal Diagnosis of ThalassemiaSemantic proximity Read ↗

Application of an optimized non-invasive prenatal testing for thalassemia based on change of haplotype doses.Semantic proximity Read ↗

Noninvasive prenatal diagnosis of β‐thalassemia by relative haplotype dosage without analyzing probandSemantic proximity Read ↗

The Next Frontier in Noninvasive Prenatal Diagnostics: Cell-Free Fetal DNA Analysis for Monogenic Disease AssessmentSemantic proximity Read ↗

Non-Invasive Prenatal Testing Using Cell Free DNA in Maternal Plasma: Recent Developments and Future ProspectsSemantic proximity Read ↗

Noninvasive prenatal testing for β-thalassemia by targeted nanopore sequencing combined with relative haplotype dosage (RHDO): a feasibility study.Semantic proximity Read ↗

Noninvasive prenatal diagnosis of monogenic diseases by targeted massively parallel sequencing of maternal plasma: application to β-thalassemia.Semantic proximity Read ↗

Non-invasive prenatal diagnosis (NIPD): how analysis of cell-free DNA in maternal plasma has changed prenatal diagnosis for monogenic disordersSemantic proximity Read ↗

Detection of paternally inherited fetal point mutations for β-thalassemia in maternal plasma using simple fetal DNA enrichment protocol with or without whole genome amplification: an accuracy assessment.Semantic proximity Read ↗

cfDNA screening and diagnosis of monogenic disorders – where are we heading?Semantic proximity Read ↗

A method for non-invasive prenatal diagnosis of monogenic autosomal recessive disordersSemantic proximity Read ↗

Fetal Fraction Signatures: A Quality Control Tool to Detect Potentially Confounding Situations in NonInvasive Prenatal Diagnosis of Monogenic Conditions.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.